Transforming growth factor β modulation of the epidermal growth factor Ca2+ signal and c-fos oncoprotein levels in A431 human epidermoid carcinoma cells

Cell Growth and Differentiation

Volumn 7, Issue 4, 1996, Pages 461-468

  Elliget, Kathryn A ^a   Phelps, Patricia C ^a   Smith, Mary W ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CALCIUM TRANSPORT; GROWTH REGULATION; HUMAN; HUMAN CELL; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

CALCIUM; CARCINOMA, SQUAMOUS CELL; EPIDERMAL GROWTH FACTOR; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOHISTOCHEMISTRY; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0029851523     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Rosner, M. R. Regulation of the epidermal growth factor receptor by growth-modulation agents Biotech. Appl. Biochem., 12: 473-477, 1990.
2. Goldkorn, T., and Mendelsohn, J. Transforming growth factor β modulates phosphorylation of the epidermal growth factor receptor and proliferation of A431 cells. Cell Growth & Differ., 3: 101-109, 1992.
3. Roberts, A. B., Frolik, C. A, Anzano, M. A, and Sporn, M. B. Transforming growth factors from neoplastic and nonneoplastic tissues. Fed. Proc., 42: 2621-2626, 1983.
4. Tucker, R. F., Shipley, G. D., Moses, H. L., and Holley, R. W. Growth inhibitor from BSC-1 cells closely related to platelet type β transforming growth factor. Science (Washington DC), 226: 705-707, 1984.
5. Takehara, K., LeRoy, E. C., and Grotendorst, G. R. TGF-β inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression. Cell, 49: 415-422, 1987.
6. 1 and other growth factors on renal proximal tubule cells. Lab. Invest, 64: 538-545, 1991.
7. 1 renal epithelial cells. Kidney Int., 45: 642-649, 1994.
8. Hepler, J. R., Nakahata, N., Lovenberg, T W., DiGuiseppi, J., Herman, B., Earp, H. S., and Harden, T. K. Epidermal growth factor stimulates the rapid accumulation of inositol (1,4,5)-trisphosphate and a rise in cytosolic calcium mobilized from intracellular stores in A431 cells. J. Biol. Chem., 262: 2951-2956, 1987.
9. 2+ signaling in A431 cells. Mol Pharmacol., 40: 254-262, 1991.
10. 2+ in A431 cells: separation of growth factor and bradykinin pathways. J. Membr. Biol., 118: 77-91, 1990.
11. Gonzales, F. A , Gross, D. J., Heppel, L. A., and Webb, W. W. Studies on the increase in cytosolic free calcium induced by epidermal growth factor, serum, and nucleotides in individual A431 cells. J. Cell. Physiol., 135: 269-276, 1988.
12. Moolenaar, W. H , Aerts, R. J., Tertoolen, L. G. J., and de Laat, S. W. The epidermal growth factor-induced calcium signal in A431 cells. J. Biol. Chem., 261: 279-284, 1986.
13. Hahm, S. H., and Cooper, R. Transforming growth factor-β 1 rapidly activates phosphorylase in a calcium-dependent manner in rat hepatocytes. FEBS Lett., 311: 37-40, 1992.
14. Grasso, P , Reichert L. E., Jr, Sporn, M. B., and Santa-Coloma, T. A. Transforming growth factor-β 1 modulates calcium metabolism in Sertoli cells. Endocrinology, 132: 1745-1749, 1993.
15. Bravo, R., Burckhardt, J., Curran, T., and Muller, R. Stimulation and inhibition of growth by EGF in different A431 cell clones is accompanied by the rapid induction of c-fos and c-myc proto-oncogenes. EMBO J., 4: 1193-1197, 1985
16. Leof, E. B., Proper, J. A., Getz, M. J., and Moses, H. L. Transforming growth factor type β regulation of actin mRNA. J. Cell. Physiol., 1227: 83-88, 1986.
17. Ignotz, R. A., Endo, T., and Massagué, J. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-β. J Biol. Chem , 262: 6443-6446, 1987.
18. Alexandrow, M. G., and Moses, H. L. Transforming growth factor β and cell cycle regulation. Cancer Res., 55: 1452-1457, 1995.
19. Wrana, J. L., Attlsano, L., Wleser, R., Ventura, F., and Massagué, J. Mechanism of activation of the TGF-β receptor. Nature (Lond.), 370: 341-347, 1994.
20. Kawabata, M., Chytil, A., and Moses, H. L. Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-β receptor. J. Biol. Chem., 270: 5625-5630, 1995.
21. Ullrich, A., Coussens, L., Hayflick, J. S., Dull, T. J., Gray, A., Tam, A. W., Lee, J., Yarden, T., Libermann, T. A., Schlessinger, J., Downward, J., Mayes, E. L. V , Whittle, N., Waterfield, M. D., and Seeburg, P. H. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (Lond.), 309: 418-425, 1984
22. Yang, K., Reddel, R. R , Gerwin, B. I., Miyashita, M., McMenamin, M., Lechner, J. F., and Harris, C. C. Human bronchial epithelial cells with integrated SV40 virus T antigen genes retain the ability to undergo squamous differentiation. Differentiation, 38: 60-66, 1988.
23. Gill, G. N , and Lazar, C. S. Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells. Nature (Lond.), 293: 305-307, 1981.
24. Putney, J. W., Jr. Excitement about calcium signaling in inexcitable cells. Science (Washington DC), 262: 676-678, 1993.
25. Murthy, U., Rieman, D. J., and Rodeck, U. Inhibition of TGFα-induced second messengers by anti-EGF receptor antibody-425. Biochem. Biophys. Res. Commun. 172: 471-476, 1990.
26. 2+] gradient in smooth muscle by protein phosphorylation. FASEB J., 8: 879-883, 1994.
27. Tidball, J. G., and Spencer, M. J. PDGF stimulation induces phosphorylation of talin and cytoskeletal reorganization in skeletal muscle. J. Cell Biol., 123: 627-635, 1993.
28. Cohen, P. Signal integration at the level of protein kinases, protein phosphatases and their substrates. Trends Biochem. Sci., 17: 408-413, 1992.
29. 2+ influx. Nature (Lond.), 364: 809-814, 1993.
30. 2 Cell Calcium, 17: 453-458, 1995.
31. Muldoon, L. L , Rodland, K. D , and Magun, B. E, Transforming growth factor β and epidermal growth factor alter calcium influx and phosphatidyl-inositol turnover in rat-1 fibroblasts. J. Biol. Chem., 263: 18834-18841, 1988.
32. Joiakim, A. P., and Chopra, D. P. Retinoic acid and calcium regulation of p53, transforming growth factor-β 1, and transforming growth factor-α gene expression and growth in adenovirus 12-SV40-transformed human tracheal gland epithelial cells. Am. J. Resp. Cell & Mol. Biol., 8: 408-416, 1993.
33. Curran, T., and Morgan, J I. Superinduction of c-fos by nerve growth factor in the presence of peripherally active benzodiazepines. Science (Washington DC), 229: 1265-1268, 1985.
34. Cutry, A. F., Kinniburgh, A. J., Krabak, M. J., Hui, S-W., and Wenner, C. E. Induction of c-fos and c-myc proto-oncogene expression by epidermal growth factor and transforming growth factor a is calcium-independent. J. Biol. Chem., 264: 19700-19705, 1989.
35. Massagué, J., and Like, B. Cellular receptors for type β transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. J. Biol. Chem., 260: 2636-2645, 1985.
36. Laemmli, U. K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature (Lond.), 227, 680-685, 1970.
37. Trump, B. F., Berezesky, I. K , and Smith, M. W Cellular calcium and mitochondrial dysfunction. In. D. P. Jones and L. H. Lash (eds.), Methods in Toxicology: Mitochondrial Dysfunction, Vol. 2, pp. 337-353. New York: Academic Press, 1993.
38. 2+ in individual rabbit proximal tubule cells. Am. J. Physiol., 262: F647-F655, 1992.